Market revenue in 2023 | USD 5,428.3 million |
Market revenue in 2030 | USD 10,511.5 million |
Growth rate | 9.9% (CAGR from 2023 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments |
Key market players worldwide | Sartorius AG, Danaher Corp, Merck KGaA, Thermo Fisher Scientific Inc, Corning Inc, Avantor Inc, BD, Eppendorf, Bio-Techne Corp, PromoCell GmbH |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell culture market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 58.01% in 2023. Horizon Databook has segmented the U.S. cell culture market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. market for cell culture is expected to witness lucrative growth as it is the biggest market for biotechnology & biopharmaceuticals and a leader in biopharmaceutical R&D. According to data published by PhRMA in 2018, the U.S. biopharmaceutical industry invested around USD 102 billion in R&D activities. Furthermore, the high prevalence of chronic diseases, such as cancer, and extensive R&D activities by regional players to develop novel cell & gene therapies are expected to fuel the demand for cell culture solutions.
As per the American Cancer Society’s estimates, in 2021, around 1.9 million new cases of cancer were estimated to be diagnosed in the U.S., with over 608,570 cancer related deaths. In addition, following the outbreak of COVID‐19, several U.S.-based companies were involved in extensive research for the development of novel vaccines & therapeutics, driving the demand for cell culture solutions for various research applications.
In addition, the local presence of major players like Thermo Fisher Scientific, BD, & Danaher in the country and strategic initiatives undertaken by key players are anticipated to fuel the market growth. For instance, in November 2022, Fujifilm announced an investment of USD 188 million to construct a cell culture media manufacturing plant in North Carolina.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. cell culture market , including forecasts for subscribers. This country databook contains high-level insights into U.S. cell culture market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account